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Chd7 is indispensable for mammalian brain
development through activation of a neuronal
differentiation programme
Weijun Feng1,*, Daisuke Kawauchi2,*, Huiqin Körkel-Qu1, Huan Deng1, Elisabeth Serger1, Laura Sieber2,
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Mutations in chromatin modifier genes are frequently associated with neurodevelopmental
diseases. We herein demonstrate that the chromodomain helicase DNA-binding protein
7 (Chd7), frequently associated with CHARGE syndrome, is indispensable for normal
cerebellar development. Genetic inactivation of Chd7 in cerebellar granule neuron progenitors
leads to cerebellar hypoplasia in mice, due to the impairment of granule neuron
differentiation, induction of apoptosis and abnormal localization of Purkinje cells,
which closely recapitulates known clinical features in the cerebella of CHARGE patients.
Combinatory molecular analyses reveal that Chd7 is required for the maintenance of open
chromatin and thus activation of genes essential for granule neuron differentiation. We
further demonstrate that both Chd7 and Top2b are necessary for the transcription of a set of
long neuronal genes in cerebellar granule neurons. Altogether, our comprehensive analyses
reveal a mechanism with chromatin remodellers governing brain development via controlling
a core transcriptional programme for cell-specific differentiation.
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T
he chromatin structure plays a central role in any
DNA-dependent biological process such as transcription,
DNA replication and DNA repair. Recurrent mutations of
chromatin modifier genes have been identified by extensive high-
throughput sequencing of a broad spectrum of human patient
samples. These findings reveal perturbation of the epigenome as
a new hallmark of cancer1 and neurological diseases2. This strong
correlative evidence requires further functional validation to fully
understand the role of chromatin modifiers in development and
disease, however.
Chromatin remodellers are key players in the regulation of
nucleosome positioning and thus control DNA accessibility in
eukaryotic cells. Mutations in the ATP-dependent chromatin
remodeller chromodomain, helicase, DNA binding (CHD) 7 are
the major cause of CHARGE syndrome, which is characterized by
multiple organ defects including Coloboma, Heart defect, Atresia
choanae, Retarded growth and development, Genital abnormality
and Ear abnormality3. Notably, many CHARGE syndrome patients
have brain anomalies including hypoplasia of the olfactory bulb
and cerebellum4,5 and often display an autistic phenotype6.
Moreover, CHD7 mutations have been identified in patients with
Kallmann syndrome7, autism spectrum disorders (ASD)8 as well as
subsets of patients with both congenital heart disease and
neurodevelopmental disabilities9. These findings strongly
suggest an important role of CHD7 in brain development.
Heterozygous Chd7 gene trap mice have exhibited many
CHARGE-relevant phenotypes4,10,11, supporting the role of
transgenic mice as a disease-relevant tool. Our studies and others
have utilized Chd7 conditional knockout mice to specifically dissect
the role of Chd7 in the brain, demonstrating that mutations of
Chd7 could be a causal factor for olfactory defects as well as hearing
loss and cognitive disabilities in CHARGE patients12–14. However,
the exact role of Chd7 in cerebellar development remains unclear.
In both human and mice, the cerebellum undergoes a rapid
expansion and foliation during early postnatal age. This expansion
of the cerebellum is primarily due to the fast proliferation of
cerebellar granule neuron progenitors (GNPs) in the outer external
granule layer (oEGL), which is stimulated by Sonic hedgehog (Shh)
secreted from Purkinje cells15. On the other hand, GNPs secret
a glycoprotein Reelin (Reln) to control the proper localization of
Purkinje cells15. In a precisely and temporally controlled fashion,
GNPs shift to the inner EGL (iEGL) coincident with exiting the cell
cycle15. The postmitotic cerebellar granule neurons (thereafter
called as CGNs) then migrate inwardly to reach the internal granule
layer (IGL), where they become mature. Importantly, unbalance
between GNP proliferation and differentiation can lead to cerebellar
hypoplasia or tumour formation16. Emerging data demonstrate that
chromatin landscape is dynamically changed during differentiation
of cerebellar granule cells, implicating an important role of
chromatin regulation in neuronal differentiation17,18. Indeed,
cerebellar anomalies including vermis hypoplasia and massive
Purkinje cell heterotopia represent some of the most prominent
features of CHARGE patients4,19, strongly suggesting that CHD7 is
essential for normal cerebellar development.
Here, we report in vivo evidence for an essential role of Chd7
during cerebellar development. Using genetic and biochemical
approaches, we unravel molecular mechanisms of how Chd7
controls neuron differentiation to govern proper formation of the
cerebellar architecture. These results provide not only new
molecular insights into cellular differentiation, but also a better
understanding of Chd7-associated human diseases.
Results
Chd7 is highly expressed in cerebellar granule cells. Many
CHARGE patients carrying CHD7 mutations have defects in the
cerebellum, implicating a functional role of CHD7 in cerebellar
development. In support, expression of CHD7 is enriched in the
cerebellum during human brain development when compared to
the other brain regions (Supplementary Fig. 1a). To investigate
the contribution of Chd7 to cerebellar development, we examined
detailed spatial and temporal expression patterns of Chd7 in
developing mouse cerebellum. Immunohistochemistry (IHC)
with a Chd7 antibody at embryonic day (E) 14.5 revealed a higher
expression of Chd7 in the external granule layer (EGL) as com-
pared to cells in the ventricular zone (Fig. 1a). Chd7 is highly
expressed in cells from EGL and IGL at neonates and persists in
the IGL at P21 cerebella (Fig. 1a). A very similar expression
pattern of GFP was observed in a bacterial artificial chromosome-
based Chd7-GFP reporter mouse line carrying GFP fused to the
Chd7 regulatory element (Fig. 1a, lower panels). Consistent with
the expression of Chd7 protein, in situ hybridization data
revealed that Chd7 mRNA was clearly detected in EGL at E14.5,
and in the granule layer at P7 and adult cerebellum
(Supplementary Fig. 1b). We next performed co-immunostaining
assays to check the co-expression of Chd7 or GFP with cell
type-specific markers in the cerebella of wild-type (WT) or
Chd7-GFP reporter mice, respectively. Exampled as P7 cere-
bellum, over 90% of Pax6þ or Pax2þ cells, namely cerebellar
granule cells or inhibitory interneuron progenitors, respectively,
expressed GFP in Chd7-GFP mice (Fig. 1b). In contrast,
Bergmann glia (Sox2þ ) and Purkinje cells (Calbindinþ ) only
showed a very weak expression of Chd7 (Fig. 1c).
Intriguingly, higher levels of Chd7 were detected in iEGL,
where cells have just exited cell cycle (p27þ ) as compared to
proliferating GNPs (Ki67þ ) in oEGL (Fig. 1d). In support,
quantitative RT–PCR (qRT-PCR) data of cultured granule cells
validated a higher expression of Chd7 in postmitotic (Ccnd1-low)
cells than proliferating (Ccnd1-high) cells (Fig. 1e). These
data suggest that the expression of Chd7 is upregulated during
the transition from proliferating into differentiated cerebellar
granule cells.
Disruption of Chd7 in GNP leads to cerebellar hypoplasia. To
examine roles of Chd7 during cerebellar development, we next
genetically ablated Chd7 in vivo using Chd7 conditional knockout
mice12. We first utilized a Nestin-Cre driver to target neural stem
cells in the brain. The homozygous mutant [Nestin-Cre::Chd7f/f]
mice exhibited largely perinatal lethality (Supplementary Fig. 2a).
We observed conspicuous cerebellar hypoplasia in survived
homozygous mutant mice (Supplementary Fig. 2b). To dissect
the role of Chd7 in cerebellar development and overcome the
lethality of Nestin-Cre-mediated Chd7 deletion, we decided to use
cerebellar neuron-specific Cre drivers. The cerebellar neuroepi-
thelium (Nestinþ ) is mainly divided into two compartments
during embryogenesis: the upper rhombic lip (Atoh1þ ) and the
cerebellar ventricular zone (Ptf1aþ ) that give rise to excitatory
(for example, granule cells) and inhibitory neurons (for example,
Purkinje cells), respectively15. Given that Chd7 is predominantly
expressed in granule cells (Fig. 1), we first ablated Chd7 in
Atoh1þ cells. IHC assays with a Chd7 antibody performed in P7
cerebella (Supplementary Fig. 3a) and in vitro cultured granule
cells (Supplementary Fig. 3b) verified ablation of Chd7 in granule
cells of [Atoh1-Cre::Chd7f/f] homozygous mutant mice. While no
structural anomalies of the cerebella were observed at E15.5, P0
and older [Atoh1-Cre::Chd7f/f] homozygous mutant mice, but not
[Atoh1-Cre::Chd7f/þ ] heterozygous mutant cerebella showed
severe defects in folia formation and cerebellar hypoplasia
especially in the vermis (Fig. 2a, Supplementary Fig. 3c). The
cerebellar defects in Chd7 mutant animals are more prominent in
the anterior lobe (Fig. 2a). This is consistent with the previous
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report20 and a remaining Chd7 protein in the posterior lobe
(Supplementary Fig. 3d), which is probably due to the less
recombination efficiency of the Atoh1-Cre mouse line.
The crosstalk between GNPs and Purkinje cells is essential
for cerebellar development, as revealed by severe cerebellum
hypoplasia in Reln-deficient reeler mice21. Since massive
Purkinje cell heterotopia has been reported in CHARGE
patient brains19,22, we next examined Purkinje cells in
[Atoh1-Cre::Chd7f/f] mutant mice. Although the Atoh1-Cre
driver does not target Purkinje cells, abnormal distribution of
Purkinje cells were clearly detected in cerebella from P0 onwards
until adult, especially at the anterior lobe of the cerebellum
(Fig. 2b, arrowheads). Importantly, we did not observe any
abnormal phenotype of Purkinje cells, when directly targeting
Chd7 in Purkinje cells using a Ptf1a-Cre driver23 (Fig. 2c).
Therefore, our findings suggest that the Purkinje cell phenotype
in Chd7 mutant mice and very likely in CHARGE patients
is not due to a Purkinje cell-autonomous effect, but rather
results from Chd7 loss in granule cells.
Chd7 regulates neuronal differentiation and cell survival.
To dissect cellular mechanisms responsible for the cerebellar
hypoplasia phenotype of Chd7-deficient mice, we analysed
cell proliferation, differentiation, cell death and migration
of granule cells during cerebellar development. Two-hour
in vivo pulse-labelling of BrdU or IdU revealed similar percen-
tages of proliferating GNPs between Chd7 WT [Chd7f/f] and
Chd7-deficient [Atoh1-Cre::Chd7f/f] cerebella at both P0 and
P3 (Fig. 3a). As further validation, we freshly isolated GNPs at
P7 using a percoll gradient centrifugation24 after pulse-labelling
of BrdU 2 h before the killing. The FAC-based cell cycle analysis
revealed no significant change of the ratio of proliferating cells
between WT and Chd7-deficient mice (Supplementary Fig. 3e).
Together, these data revealed that the proliferation capacity of
Chd7-deficient GNPs seems comparable to WT cells. However,
24-h BrdU labelling at P6 followed by co-staining of BrdU and
Ki67 at P7 showed less Ki67-negative cells among BrdU-positive
cells in the EGL of Chd7-deficient mice, indicating that Chd7 loss
prevents appropriate cell cycle exit of GNPs in vivo (Fig. 3b).
Failure of cell cycle exit of Chd7 mutant GNPs implicates less
differentiated granule cells. Indeed, IHC analysis with a neuronal
marker NeuN revealed significantly less granule neurons in the
IGL of Chd7 mutant than WT cerebella (Fig. 3c). The decrease of
granule neurons in Chd7 mutant cerebella was confirmed by the
counting of BrdUþ cells in IGLs of P7 pups that were pulsed and
traced with BrdU for 48 h (Supplementary Fig. 3f). Moreover,
IHC for cleaved caspase3 detected more apoptotic cells in the
Chd7-deficient EGL at postnatal stages (Fig. 3d). In line with this
observation, Chd7 loss significantly increased cell death as
detected by staining of cleaved caspase3 and Parp in cultured
granule cells especially in absence of SHH (Fig. 3e), indicating
that mutant cells are more prone to cell death upon
differentiation. Meanwhile, we did not observe defects in the
migration of granule cells in Chd7-deficient cerebella, as shown
by BrdU labelling and tracing (for 48 h) assay (Supplementary
Fig. 3f). Thus, our data suggest that cerebellar hypoplasia in





































































Figure 1 | Chd7 is highly expressed in cerebellar granule cells. (a) Immunostaining of Chd7 (red, upper panels) and Chd7-GFP (green, lower panels) in
a time series of mouse cerebellum during development. Cellular nuclei were counterstained with DAPI (blue). Scale bars, 100 mm. EGL, external granule
layer; IGL, internal granule layer. (b) Co-immunostaining of GFP (green) with Pax6 (red, upper panels) and Pax2 (red, lower panels) in the IGL of cerebella
of P7 Chd7-GFP reporter mice. Scale bars, 10mm. The bar graph shows the quantification of percentages of Chd7-GFPþ cells either in Pax6þ or Pax2þ
cells. (c) Co-immunostaining of Chd7 with Sox2 (red, upper panels) and Calbindin (red, lower panels) in cerebella of P7 wild-type C57BL/6J mouse.
Arrowheads show very weak staining of Chd7 in Sox2þ or Calbindinþ cells. Scale bars, 50mm. (d) Co-immunostaining of Chd7 (green) with Ki67 (red,
upper panels) and p27 (red, lower panels) in EGL of P7 cerebellum. Scale bars, 25mm. oEGL: outer EGL. iEGL: inner EGL. (e) Quantitative reverse
transcription PCR (qRT–PCR) results show the expression level of Chd7 and Ccnd1 in granule neuron progenitors (GNPs) cultured with or without (w/o)
Sonic Hedgehog (Shh) for 48 h. The level of Gapdh transcripts was used for normalization. Bars represent normalized mean value ± s.d. from three
independent samples. Paired two-tailed t-test with equal variance was performed, P¼0.031 (for Chd7), P¼0.0001 (for Ccnd1).
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cell-autonomous effect (that is, a failure of GNP differentiation
and increased cell death) and non-autonomous effects from
the abnormal distribution of Purkinje cells.
Chd7 loss alters expression of neuronal genes. To explore
molecular consequences of Chd7 loss in GNPs, we next
performed RNA sequencing (RNA-seq)-based transcriptome
analysis using freshly isolated GNPs from P7 Chd7 WT, hetero-
zygous [Atoh1-Cre::Chd7f/þ ] (Chd7 Het.) and homozygous
[Atoh1-Cre::Chd7f/f] (Chd7 Hom.) mutant cerebella. Results from
qRT–PCR showed a significant decrease of Chd7 transcripts
according to their genotypes in Chd7 Het. and Chd7 Hom.
mutant GNPs as compared to WT GNPs (Fig. 4a). At the
significance of Po0.01, 151 genes were downregulated in Chd7
Hom. GNPs, with many of them (62.9%, 95/151, Po0.05
between WT and Chd7 Het.) significantly downregulated in
Chd7 Het. GNPs (Fig. 4b), suggesting a dosage-dependent reg-
ulation of these genes by Chd7. Importantly, DAVID Gene
Ontology (GO) term analysis of genes downregulated upon loss
of Chd7 demonstrated neuronal functions including synaptic
transmission, ion transport, neuron development and neuron
differentiation as the most enriched biological processes (Fig. 4c),
while no significantly enriched term (Benjamini adjusted
P valueo0.05) was identified in genes significantly upregulated
upon Chd7 loss. For instance, the proper level of Chd7
is necessary for the expression of neural genes that are important
for cerebellar development, including Cadps2, Gap43, Neurod1,
Reln and Unc5c (refs 25–29) (Fig. 4d, Supplementary Fig. 4a).
Consistent with downregulation of Reln, IHC analyses
demonstrated that Dab1, the adaptor protein of Reln signalling
pathway, was upregulated specifically in mislocalized Purkinje
cells in Chd7 mutant cerebella (Supplementary Fig. 4b) in
accordance with observation in the reeler mice21. To exclude the
long-term or indirect effect of Chd7 loss on gene expression,
we acutely ablated the expression of Chd7 by treating
[Chd7f/f] or WT granule cells with cell-permeable Cre for 48 h.































































Atoh1-Cre::Chd7 f/fChd7 f/fAtoh1-Cre::Chd7 f/f
Atoh1-Cre::Chd7 f/f
P7
Figure 2 | Genetic ablation of Chd7 in GNPs leads to cerebellar hypoplasia and Purkinje cell ectopia. (a) Nissl staining of E15.5, P0, P7 and adult
cerebella including vermis and hemisphere from [Chd7f/f] and [Atoh1-Cre::Chd7f/f] mice. Left side in each panel is the anterior part of cerebella. Scale bars,
100mm. (b) Co-immunostaining of Calbindin (red), a marker for Purkinje cells (PCs) in P0, P3, P7 and adult WT [Chd7f/f] and Chd7 mutant [Atoh1-
Cre::Chd7f/f] cerebella. Cellular nuclei are counterstained with DAPI (blue). Arrowheads indicate clusters of mislocalized PCs. Scale bars, 200mm.
Quantification of the percentage of mislocalized PCs among all PCs in anterior lobule I-V is shown in the left panel. Cerebellar sections from three
independent P3 and six P7 Chd7 mutant mice were counted. (c) Immunostaining of Calbindin in cerebella of P7 and adult WT [Chd7f/f] and Chd7 mutant
[Ptf1a-Cre::Chd7f/f] mice. Sections were counterstained with haematoxylin. Scale bars, 100 mm.
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of Chd7 regulated genes identified above (Supplementary
Fig. 4c).
To identify direct target genes of Chd7, we performed chromatin-
immunoprecipitation coupled to sequencing (ChIP-seq) using
freshly isolated P7 GNPs. In order to identify bona fide
Chd7-binding sites, we in parallel performed Chd7 ChIP-seq on
Chd7-deficient GNPs. Using the MACS (Model-based Analysis
of ChIP-seq) peak calling method, 1,946 peaks were called from
WT cells, in contrast to only 96 peaks called from Chd7-deficient
cells. In consistency with reports showing that Chd7 preferentially
binds to enhancers in ESCs and oligodendrocytes30,31, Chd7-
occupied regions in GNPs are enriched of H3K27ac, a histone mark
for active promoters and enhancers (Fig. 4e). Furthermore, Chd7
was enriched in super-enhancers (SEs) defined by H3K27ac ChIP-
seq on GNPs (ref. 31) (Fig. 4f,g, Supplementary Fig. 5b). GO
analysis revealed a strong enrichment of Chd7-associated genes in
biological processes like transcription, chromatin organization,
neuron differentiation and neuron projection morphogenesis
(Supplementary Fig. 5a). Among genes whose expression was
significantly altered upon loss of Chd7 (Po0.05), 12.5% (93/746)
downregulated and 9.9% (99/1002) upregulated genes showed
association of Chd7. For instance, Chd7 binds Chd7-activated
genes, including Neurod1, Cadps2, Gap43 and Reln (Fig. 4g,
Supplementary Fig. 5b).
As Chd7 functions as an ATP-dependent nucleosome
remodeller32, we hypothesized that Chd7 regulates transcription
via controlling DNA accessibility of cis-regulatory elements.
For this, we utilized an assay for Tn5 transposase-accessible
chromatin with high-throughput sequencing (ATAC-seq) (ref. 33)
and generated a genome-wide map of the open chromatin
landscape in Chd7 WT and mutant GNPs at P7. As expected,
most of H3K27ac ChIP-seq peaks (81.9%) colocalized with ATAC-
seq peaks (Supplementary Fig. 6a). A small subset of ATAC-seq
peaks showed significant alteration upon loss of Chd7 (2.1%), with
Chd7 Het. cells exhibiting intermediate change between WT and
Chd7 Hom. (Supplementary Fig. 6b). GO analysis of genes
containing altered ATAC-seq peaks called transmission of nerve
impulse, cell motion and cell adhesion as the most enriched
biological processes (Supplementary Fig. 6c). Among genes whose
expression was significantly changed upon loss of Chd7 (Po0.05),
14.2% (106/746) downregulated and 4.5% (45/1002) upregulated
genes showed altered ATAC-seq peak. For instance, decreased
ATAC-peaks upon Chd7 loss were detected in Chd7-activated
genes including Cadps2, Nkain3, Reln, Bmp5 and Fstl5 (Fig. 4h,
Supplementary Fig. 6d). Moreover, 22.8% (320/1402) of genes
bound by Chd7 in GNPs showed altered ATAC-seq peaks upon
Chd7 loss, revealing that the association of Chd7 is required for the
maintenance open chromatin on these genes. Collectively,
comprehensive analysis of ChIP-seq and ATAC-seq data
(for example, Supplementary Table 1) demonstrate that Chd7 is
involved in the maintenance of open chromatin at the regulatory



























































































































































Figure 3 | Mutation of Chd7 in GNPs impairs neuronal differentiation and leads to cell death. (a) Immunostaining of BrdU (brown) in P0 and IdU (red) in
P3 cerebella from WT [Chd7f/f] and Chd7 mutant [Atoh1-Cre::Chd7f/f] mice pulse-labelled with BrdU or IdU for 2 h before the killing. The dashed lines show
the inner border of EGL in P3 cerebella. Scale bars, 100mm. Quantification of the percentage of BrdU- or IdU-positive cells in the EGL within selected
areas is shown in the right panel. Bars represent mean value ± s.d. from four mice for each group (for P0) and three mice for each group (for P3).
(b) Co-immunostaining of BrdU (green) and Ki67 (red) in anterior cerebellar lobules of P7 WT and Chd7 mutant mice subjected to BrdU administration
24 h before the killing. Scale bars, 50mm. The graph represents the percentage of Ki67-negative cells among BrdU-positive cells. Bars represent mean value
± s.d. from three mice for each group. P¼0.047. (c) Immunostaining of NeuN in anterior cerebellar lobules of P3 WT and Chd7 mutant mice. Scale bars,
50mm. Quantification of the number of NeuNþ cells in IGL is shown in the right panel. Bars represent mean value ± s.d. from three mice for each group.
P¼0.035. (d) IHC of cleaved-caspase3 in P0 and P7 cerebella of WT and Chd7 mutant mice. Scale bars, 50mm. The number of cleaved caspase3-positive
cells (indicated by arrows) in the whole EGL of cerebellar sections was counted (right panels). Bars represent mean value ± s.d. from four mice for each
group (for P0, P¼0.0027) and three mice for each group (for P7, P¼0.024). (e) Immunostaining of cleaved caspase3 in WT and Chd7 mutant GNPs
cultured with or without (w/o) Shh for 48 h (left panels). The percentage of cleaved caspase3-positive cells (green) among DAPI-stained cells (blue) was
quantified (middle panel). Scale bars, 50mm. The expression level of Parp, cleaved parp and cleaved caspase3 in WT and Chd7 mutant GNPs cultured
without Shh shown by western blots (right panels). Bars represent mean value ± s.d. from five randomly selected areas. P¼ 2.1E-5 (for Shh); P¼ 7.7E-5
(for w/o Shh).
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Chd7 regulates granule cell differentiation with Top2b. To get
insight into molecular mechanisms underlying Chd7-dependent
transcriptional regulation, we aimed at identifying CHD7-inter-
acting proteins using immunoprecipitation (IP) coupled with
mass spectrometry (MS). For efficient IP with a sufficient amount
of exogenous CHD7 protein, a Flag-tagged, truncated CHD7
(1–1,899 amino acids) that preserves nucleosome remodelling
activity in vitro32 was overexpressed and immunoprecipitated
in CHD7-deficient HEK293T cells (Supplementary Fig. 7a,b).
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BRG1, PARP1 and CHD8 (refs 34,35), DNA topoisomerases
TOP2A, TOP2B and TOP1 were identified by MS (Fig. 5a).
Protein–protein interactions between CHD7 with these proteins
were validated by co-IP assays using nucleic acids-free nuclear
extracts (Supplementary Fig. 7c) from HEK293T cells expressing
full-length Flag-tagged CHD7 (Fig. 5b). DNA topoisomerases
are key enzymes that solve the topological problems occurring
during virtually all DNA-related processes36. Inhibition of
enzymatic activities of DNA topoisomerases in postmitotic
neurons selectively represses the expression of long genes37,38.
Top2b was shown to be important for neuronal migration in
the developing neocortex by controlling the expression of Reln
(ref. 39). Therefore, we decided to further explore the functional
relevance of interaction between Chd7 and Top2b. Co-IP assays
showed the interaction between endogenous Top2b and Chd7
proteins in not only HEK293T cells but also adult cerebellar cells,
85–90% of which consist of CGNs (ref. 40) (Fig. 5c). We also
demonstrate that the N-terminal part (1–786 aa) of CHD7 is
responsible for its interaction with TOP2B, whereas KU70 does
not interact with the N-terminus of CHD7 and PARP interacts
with several regions of CHD7 (Fig. 5d).
Previous immunostaining analysis demonstrated that GNPs in
the oEGL express Top2a, whereas differentiating cells in iEGL
and differentiated CGNs in IGL only express Top2b (ref. 41).
Consistently, the transcript level of Top2a in cultured granule
cells drastically decreased upon differentiation of proliferating
GNPs (cultured with Smoothened agonist SAG) into postmitotic
(cultured without SAG) CGNs, as analysed using Affymetrix
microarray (Supplementary Fig. 8a). As Top2b is the sole
DNA topoisomerase II expressed in CGNs, we decided to use
in vitro induced postmitotic CGN to dissect the functional
interaction between Chd7 and Top2b. We performed immunos-
taining of granule cells at 1 and 48 h after plating in order to
compare the percentage of proliferating and differentiated cells
between WT and Chd7-deficient cells. At 1 h after plating, over
80% of cells were proliferating (Ki67þ ) and expressed Pax6
(Supplementary Fig. 8b). In contrast, after 48 h, most of cells
exited cell cycle (Ki67 ) and expressed p27, suggesting that these
cells were newly differentiated in culture (Supplementary Fig. 8c).
Importantly, no statistical difference of percentages of proliferat-
ing and differentiated cells between WT and Chd7 mutant cells at
these two time points were observed (Supplementary Fig. 8b,c).
To identify genes regulated by Top2b in CGNs, we performed
microarray-based gene expression analysis using cultured CGNs
treated with DMSO as a control or ICRF-193 (10 mM for 12 h),
an enzymatic inhibitor of Topoisomerase II (ref. 42). Consistent
with previous reports in cortical neurons37,38, long genes
(gene length4100 kb) were selectively downregulated in CGNs
upon treatment of ICRF-193 (Fig. 6a, left panel). The average size
of genes downregulated by ICRF-193 treatment (Po0.05, fold
change41.5) is approximately 300 kb, while the average sizes of
all genes expressed in CGNs and the genes upregulated upon
ICRF-193 treatment are both around 50 kb (Supplementary
Fig. 9a). To directly compare with Top2b-dependent
transcription, we next identified Chd7-regulated genes by
microarray analysis using Chd7 WT and homozygous mutant
CGNs. Interestingly, many long genes were significantly
downregulated upon loss of Chd7 (Fig. 6a, right panel). We
subsequently performed GSEA (Gene set enrichment analysis)
to check the concordant regulation of gene expression by
Top2b and Chd7. Genes that were significantly downregulated
upon ICRF-193 treatment showed lower expression level
in Chd7-deficient CGNs than WT cells (Fig. 6b, left panel).
Also, genes that were significantly downregulated in
Chd7-deficient CGNs were largely repressed upon ICRF-193
treatment (Fig. 6b, right panel). At the significance of Po0.05,
240 genes were commonly activated by Chd7 and Top2b in
CGNs (Supplementary Fig. 9b). Intriguingly, the average gene
length of Top2b and Chd7 co-activated genes was even longer
than those genes activated by Top2b but not Chd7 (Suppleme-
ntary Fig. 9b), implicating that transcription of these very long
genes requires both enzymes. Next, we compared expression
levels of these 240 genes between GNPs cultured with and
without SAG. Most of these 240 genes (84.6%, 203/240) were
significantly upregulated upon differentiation (Fig. 6c). Using
qRT–PCR, we validated the downregulation of ASD-related
genes involved in cerebellar development (Cadps2 and Reln)
(refs 28,43), and ASD- or epilepsy-related ion channels in
neurons (Cacna2d1, Grik2 and Kcnd2) (refs 43–45) in ICRF-193
treated or Chd7 mutant CGNs (Fig. 6d,e). Of note, Chd7
expression in CGNs was significantly downregulated upon
ICRF-193 treatment (Fig. 6d), indicating that Top2b is required
for activation of Chd7 during differentiation.
We hypothesized that Chd7 may be required for proper
targeting of Top2b to chromatin. To test this, we performed
Top2b ChIP-seq in WT and Chd7-deficient CGNs. The
expression level of Top2b in CGNs was not altered upon loss
of Chd7, at the level of both transcript and protein (Suppleme-
ntary Fig. 9c). The specificity of the Top2b antibody was verified
with ChIP analysis on WT and Top2b / mouse embryonic
fibroblasts46 using primer sets for Top2b-targeted regions at the
Fos gene (Supplementary Fig. 9d)47. We next aimed at comparing
the genome-wide binding patterns of Top2b and Chd7. Since
Chd7 ChIP-seq was done on GNPs, we performed ChIP-qPCR
assays to validate the binding of Chd7 in CGNs. Using primers
amplifying Chd7 binding regions identified by Chd7 ChIP-seq in
GNPs, we detected the association of Chd7 with multiple regions
in WT CGNs, and a clear decrease of its association in Chd7
mutant CGNs (Supplementary Fig. 9e). The comparison between
the binding pattern of Chd7 in GNPs and that of Top2b in
CGNs revealed that Top2b is associated with Chd7 binding sites
(Fig.6f, Supplementary Fig. 9f). While the average length of genes
bound by Chd7 was around 103 kb, the average gene length of
genes co-occupied by Chd7 and Top2b was approximately 165 kb,
revealing preferential binding of Chd7 and Top2b on long
genes in cerebellar granule cells. Importantly, upon loss of Chd7,
Figure 4 | Chd7 is required for activation of neuronal genes during GNP differentiation. (a) qRT–PCR analysis of Chd7 transcripts in P7 Chd7 WT
[Chd7f/f], heterozygous [Atoh1-Cre::Chd7f/þ ] and homozygous [Atoh1-Cre::Chd7f/f] mutant GNPs. The level of Gapdh transcripts was used for
normalization. Bars represent normalized mean value ± s.d. from three samples for each group. Paired two-tailed t-test with equal variance was
performed, P¼0.0034 (for Het.); P¼0.001 (for Hom.). (b) Heatmap shows significantly downregulated genes (Po0.01, the Kruskal–Wallis test) in
Chd7 mutant GNPs compared to WT. The colour scale is shown on the right. (c) DAVID Gene Ontology Biological Process analysis of genes downregulated
in Chd7 homozygous mutant GNPs compared to WT. GO terms with Benjamini adjusted P-valueo0.05 are shown. (d) Heatmap exhibits significantly
downregulated genes that are involved in neural function, in Chd7 mutant GNPs compared to WT. The colour scale is shown on the right. (e) ChIP-seq
density heatmaps for Chd7 and H3K27ac within ±5 kb of the Chd7 peak centre. (f) ChIP-seq density heatmaps show the enriched binding of Chd7 to
super-enhancers (SEs) defined by H3K27ac. The start (S) and end (E) of SEs and ±5 kb surrounding the enhancer regions are shown. (g) IGV track view of
ChIP-seq density profile for Chd7 and H3K27ac of Neurod1 and Cadps2. The SE region is highlighted with red line. (h) IGV track view of ATAC-seq density
profile (normalized to per million reads for each sample) at Cadps2 and Nkain3. The decreased ATAC-seq peaks are highlighted with grey rectangles.
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23.2% of Top2b binding sites exhibited alteration of the
association of Top2b (Fig. 6g). GO analysis of genes with
decreased Top2b ChIP-seq peaks revealed cell morphogenesis,
cell adhesion, ion transport and neuron differentiation as the
most enriched biological process (Supplementary Fig. 9g), while
no significantly (Benjamini adjusted P valueo0.05) enriched
term was detected in genes with increased peaks in Chd7-deficient
CGNs. For instance, the binding of Top2b to promoters of two
Chd7- and Top2b-activated genes Cadps2 and Cnksr3 was
decreased in Chd7 mutant CGNs compared to WT, whereas the
binding of Top2b to its known binding site at the Fos promoter
was not altered (Fig. 6h, Supplementary Fig. 9h). Importantly,
GSEA revealed that genes carrying decreased Top2b ChIP-seq
peaks in Chd7-deficient CGNs tended to be downregulated upon
ICRF-193 treatment (Fig. 6i), revealing that Chd7-dependent
recruitment of Top2b is necessary for the expression of these
genes. Furthermore, while the average length of genes bound by
Top2b (6147 genes) in WT CGNs was around 95 kb, the average
gene length of genes carrying decreased Top2b binding peak
(1190 genes) or increased Top2b binding peak (718 genes)
upon loss of Chd7 was around 153 or 115 kb, respectively. Thus,
Chd7-dependent targeting of Top2b is preferentially observed in
long genes. Moreover, we measured the amount of Top2b
covalent complexes in Chd7 WT and mutant CGNs treated with
etoposide, a DNA topoisomerase poison that traps DNA with
topoisomerases as a complex. We observed reproducible decrease,
although not statistically significant (P¼ 0.2169), of Top2b
covalent complexes in Chd7-deficient cells (Supplementary
Fig. 9i), supporting that Chd7 could contribute to the targeting
of Top2b.
Top2b regulates cerebellar development. While the reelin
signalling is essential for the proper localization of Purkinje cells27,
the cerebellar phenotype of Top2b knockout mice has not been
reported so far. To investigate this, we made use of the CRISPR-
Cas9 system to ablate Top2b in the developing cerebellum. The
cerebella of E13.5 Rosa26-CAG-LSL-Cas9-P2A-EGFP embryos were
electroporated with plasmids encoding Cre recombinase and either
sgRNA against Top2b or a negative-control sequence. The
transfection of cerebellar cells was efficient as shown at P7 by the
wide expression of GFP upon Cre-mediated recombination
(Fig. 7a). In both control and Top2b-targeted cerebella, most of
GFPþ cells in the IGL are Pax6þ (Fig. 7b), demonstrating efficient
targeting of CGNs by electroporation. Around 80% of GFPþ cells
in IGL of Top2b-targeted cerebella lost the expression of Top2b
(Fig. 7b), demonstrating high knockout efficiency by the CRISPR-
Cas9 system in vivo. Consistent with the data mentioned above
(Fig. 6d), we observed that about 40% of cells lost Chd7 expression
within transfected (GFPþ ) cells upon targeting of Top2b (Fig. 7b).
Furthermore, Top2b loss resulted in the downregulation of Zfpm2,
a common target gene of Chd7 and Top2b (see Supplementary
Data 1) (Fig. 7b). These data provide in vivo evidence that Top2b is
required for the expression of neuronal genes in granule cells.
Importantly, clusters of mislocalized Purkinje cells were observed in
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Figure 5 | Chd7 interacts with Top2b. (a) Coomassie-blue staining of an SDS gel shows immunoprecipitation using M2 beads in CHD7 KO HEK293T cells
overexpressing a Flag-tagged truncated CHD71–1,899 (highlighted with asterisk). Cells transfected with an empty vector served as mock control. Numbers
on the left side indicate the molecular weight. A list of proteins identified by mass spectrometry, peptides of which were exclusively present in CHD7-
immunoprecipitation but not mock control, is shown in the right panel. Scores and numbers of unique peptides identified for each protein are shown.
(b) Immunoblotting of CHD7-interacting proteins precipitated with M2 beads in nuclear extracts from HEK293T cells overexpressing a Flag-tagged
full-length CHD7 (F-CHD7) or mock-transfected cells. Forty per cent of IP and 2.5% of the input are shown. (c) Co-immunoprecipitation assay shows the
interaction between endogenous Chd7 and Top2b in HEK293T and adult (6-week-old) mouse cerebella. Cell lysates were immunoprecipitated with an
antibody against Top2b, and co-precipitated Chd7 was visualized by western blots. Five per cent of input and 100% of IP are shown. Note that endogenous
Chd7 in adult cerebella was only detected by western blot after enrichment by immunoprecipitation. (d) The N-terminal part of CHD7 interacts with
TOP2B. Cell lysates from HEK293T cells transfected with a series of constructs encoding Flag-tagged truncated CHD7 proteins were precipitated with
M2 beads, and precipitated proteins were visualized by western blots. Fifty per cent of IP and 4% of the input are shown. Bands corresponding to TOP2B
and KU70 according to their molecular weight are pointed with lines. The schemes illustrate the domain structure of full-length and truncated CHD7
protein used in the experiments.
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(Fig. 7c), as observed in Chd7-deficient [Atoh1-Cre::Chd7f/f] mice.
On the other hand, the percentage of proliferating (Ki67þ ) and
differentiating (p27þ ) cells among GFPþ cells in EGL were not
altered upon mutation of Top2b (Fig. 7d), similar to our previous
finding that Chd7 loss does not affect cell proliferation of GNPs.
Thus, the cerebella bearing Chd7- or Top2b-deficient granule
cells partly share similar phenotype, which supports our conclusion
that expression of a subset of neuronal genes are regulated by
Chd7 and Top2b.
Discussion
Many CHARGE patients carrying CHD7 mutation exhibit
cerebellar hypoplasia and massive Purkinje cell heterotopia4,19.
d
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In both rodents and human, cerebellar development extends
a long period from early embryonic stage until the first postnatal
weeks (in mouse) or years (in human). One recent study revealed
that Chd7 is necessary for cerebellum specification during
early embryogenesis (around E8.5 in mouse) using Chd7 gene
trap mice4. However, the contribution of Chd7 during
later cerebellar development and its implication in CHARGE
syndrome has not been studied, however. In this study, cell type-
specific inactivation of the Chd7 gene using multiple Cre drivers
identified failure of cerebellar granule cells differentiation as
a contributing factor for cerebellar hypoplasia and Purkinje cell
heterotopia. RNA-seq analysis revealed impaired downregulation
of Reln in Chd7-deficient GNPs, by which mislocalization
of Purkinje cells could be explained as observed in reeler
mice21,48,49. Mechanistically, Chd7 is specifically associated with
and is required for the activation of a core neuronal differen-
tiation programme through maintaining the open chromatin
structure and recruiting DNA topoisomerase IIb to these genes.
Our data provide a clear epigenetic mechanism of Chd7-mediated
gene transcriptional regulation in vivo, thus shedding light on
epigenetic mutation-associated human diseases.
Our previous study revealed that loss of Chd7 in adult neural
stem cells impaired the transcriptional activation of two essential
neurogenic transcription factors Sox4 and Sox11, leading to
defects of both the quantity and quality of newborn neurons12. In
the current study, we made use of the abundance of primary
cerebellar granule cells to perform comprehensive molecular
analyses. Expression profiling data clearly revealed that Chd7 is
required for the activation of genes involved in neural functions.
ChIP-seq on freshly isolated GNPs demonstrated that Chd7
occupies active chromatin regions in genes involved in
transcription and neuronal functions. Consistent with the result
from human embryonic stem cells31, Chd7 was found to be
associated with SEs, which exhibit densely spaced clusters of
active histone marks H3K27ac and clustered occupancy of cell
identity-specific transcription factors. The binding of these
transcription factors forming self-reinforcing circuits within
SEs shapes cell-type-specific transcriptional landscape and
thus governs cell identity. Interestingly, two SEs were identified
within the Chd7 gene, co-occupied by Chd7 protein and H3K27ac
(Supplementary Fig. 5b), implicating that Chd7 could be a key
chromatin regulator of cell identity in GNPs. In accordance with
our study, a very recent investigation revealed an essential role
of Chd7 in the onset of myelination via targeting the enhancers
of key myelinogenic genes30.
Both chromatin remodellers and DNA topoisomerases are
crucial enzymes involved in DNA-related processes. The
cooperative action of these two groups of enzymes was
not appreciated until very recently50. In this study, we revealed
the collaboration between Chd7 and DNA topoisomerases Top2b
to activate the expression of long neuronal genes. As an example,
our molecular analyses identified Reln as a common target of both
Chd7 and Top2b. Importantly, depletion of Top2b using Foxg1-
Cre, a forebrain-specific Cre driver, leads to aberrant lamination
of cerebral cortex due to the repression of Reln (ref. 39). Here, we
demonstrated that the enzymatic activity of Top2b is crucial for
the expression of Reln in cerebellar granule cells and genetic
ablation of Top2b in cerebellum during development leads to
mislocalization of Purkinje cells that is very likely due to lack of
reelin signalling (Fig. 6c). In cortical neurons, the enzymatic
activities of Top2b and Top1 are particularly necessary for
transcription of long genes38. It has been thought that
transcription of very long genes causes more supercoiled
DNA double helix structures on these genes, thus requiring
Top enzymes to solve this topological issue during transcriptional
elongation. Our results suggest that besides DNA topoisomerases,
chromatin-remodelling activity is critical for transcription of very
long genes. Two recent studies have revealed the cooperation
between another chromatin remodeller the BAF complex with
DNA topoisomerases. The first study demonstrated that in
dividing cells, the BAF complex interacts with Top2a and
regulates Top2a-mediated decantenation activity during
mitosis50. The second study revealed that the BAF complex-
dependent chromatin remodelling activity is required for the
Top1-mediated gene activation during inflammation51. Here, we
observed Chd7 interacts with several topoisomerases including
Top1, Top2a and Top2b (Fig. 5a). It will be of great interest to
explore the potential functional interaction between Chd7 and
Top1 in postmitotic neurons and Top2a in dividing cells.
Furthermore, as reported in a previous study34 and our current
study (Fig. 5a), CHD7 protein interacts with the BAF complex. It
could be interesting to investigate the cooperation action among
CHD7, BAF complex and DNA topoisomerase.
The rapid progress of genomic sequencing technology has
provided novel insights into genetic causes of many human
diseases. On the other hand, the causal role of most of these
newly identified mutations needs to be experimentally validated.
It is striking that most of the patients carrying CHD7 mutations
display neurological disabilities, suggesting that CHD7 is a master
chromatin regulator for brain function. Using mouse genetics, we
here discovered that Chd7 controls a core neuronal differentia-
tion programme during cerebellar granule cell differentiation.
Importantly, 16 out of the 151 genes (P¼ 3.146E-15, Chi-square
test) that were significantly downregulated in Chd7-deficient
GNPs (Fig. 4b, Supplementary Data 1) were previously found as
genetic mutation(s) in ASD patients (http://www.sfari.org).
Furthermore, among 240 identified Chd7 and Top2b common
activated genes in CGNs (Fig. 6c, Supplementary Data 1),
Figure 6 | Chd7 recruits Top2b to activate long neuronal genes. (a) Volcano plots depict gene expression changes (Po0.05) between CGNs treated with
ICRF-193 or DMSO (left panel) and between WT [Chd7f/f] and Chd7 homozygous mutant [Atoh1-Cre::Chd7f/f] CGNs (right panel). Genes longer than
100 kb are labelled as red dots. The grey lines show the position of fold change of 1.5. (b) Gene Set Enrichment Analysis (GSEA) of genes that were
significantly downregulated (Po0.01) in CGNs upon ICRF-193 treatment in WTand Chd7 mutant CGNs (left panel) and were significantly downregulated in
Chd7 mutant CGNs (Po0.01) in ICRF-193- and DMSO-treated WT CGNs (right panel). Po0.001. NES: Normalized Enrichment Score. (c) Heatmap of
the expression of genes activated by both Chd7 and Top2b in WT and Chd7 mutant CGNs, and ICRF-193- or DMSO-treated CGNs and cells cultured with
(GNPs) or without SAG (CGNs). The colour scale is shown on the right. (d) qRT–PCR analysis represented Top2b-activated genes in CGNs. The level of
Gapdh transcripts was used for normalization. Bars represent normalized mean value ± s.d. from four samples for each group. P¼0.0003; 0.001; 0.0035;
0.005; 0.0006; 1.0E-5 (from left to right). (e) qRT–PCR analysis of the represented genes in Chd7 WTand mutant CGNs. The level of Gapdh transcripts was
used for normalization. Bars represent normalized mean value ± s.d. from four samples for each group. P¼0.001; 1.8E-5; 0.0004; 0.028; 0.035;
0.0016 (from left to right). (f) ChIP-seq density heatmaps for Chd7 in GNPs and Top2b in CGNs within ±2 kb of the Chd7 peak centre. (g) ChIP-seq
density heatmaps depict altered Top2b ChIP-seq peaks (Po0.01, fold change42) between WT and Chd7 mutant CGNs. Regions within ±2 kb of the
Top2b peak centre are shown. (h) Track view of ChIP-seq density profile for Chd7 in GNPs and Top2b in WT and Chd7 mutant CGNs in the region upstream
of Cadps2 gene. (i) GSEA of selected genes that have at least one decreased Top2b ChIP-seq peak in Chd7-deficient CGNs in ICRF-193- and DMSO-treated
WT CGNs. Po0.001.
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mutations of 35 genes are associated with ASD (Po2.2E-16,
Chi-square test). Emerging evidence has linked the cerebellum
with higher cognitive functions. Indeed, cerebellar deficits have
long been implicated in autism52. Our study provides supporting
evidence showing Chd7-dependent regulation of transcription
is involved in the pathogenesis of autism. Moreover, many
Chd7-regulated genes identified in this study, such as Gap43,
Cadps2 and Reln, function in other brain regions besides
cerebellum21,26,53. Thus, the molecular network controlled by
Chd7 maybe a core network for brain development and function
in human.
Methods
Animals. Chd7 conditional knockout mice were generated by breeding of
Chd7f/f (ref. 12) with Nestin-Cre (JAX, #003771), Atoh1-Cre (JAX, #011104)
and Ptf1a-Cre mice (BCBC, RES184). Chd7-GFP (from the GENSAT project,
http://www.gensat.org/index.html) and Rosa26-CAG-LSL-Cas9-P2A-EGFP
(JAX, #024857) mice were purchased. Mice were housed in a vivarium with
a 12-h light/dark cycle. All mice were bred in C57BL/6N background. Genotyping
primers are listed in Supplementary Table 2. For in utero electroporation
experiments, Rosa26-CAG-LSL-Cas9-P2A-EGFP homozygous knockin male mice
were crossed with CD-1 female mice, yielding embryos carrying Rosa26-CAG-LSL-
Cas9-P2A-EGFP heterozygous genotypes. For in vivo BrdU or IdU labelling,
animals were subjected to intraperitoneal injection of BrdU or IdU (3 mg per 40 g
body weight) and were killed at defined stages. All animal experiments were
conducted according to animal welfare regulations and have been approved by
the responsible authorities (Regierungspräsidium Karlsruhe, approval numbers:
G32/14, G48/14 and G90/13).
Plasmids. The human CHD7 (1–1,899) cDNA with a C-terminal Flag tag was
amplified from pFastbac-CHD7 (1-1,899) (a gift from Robert Kingston)32, and
cloned into pEF-DEST51 using the Gateway technology (Thermo Fisher Scientific).
The full-length CHD7 expression construct containing an N-terminal GFP tag
was inserted into the Flag-tagged CHD7-encoding expression plasmid34. The
truncated CHD7 constructs were generated by the insertion of PCR products
into pcDNA3.1 empty vector. The coding sequence of sgRNA against CHD7
(CTTTCTAGAGAAACCAGTGC) was cloned into pLenti-CRISPR v2
(Addgene #52961). For genetic ablation of Top2b, the coding sequence of sgRNA
























































































Figure 7 | Genetic ablation of Top2b leads to phenotypic changes analogous to Chd7-deficient cerebella. (a) Immunostaining of GFP (green)
on P7 cerebellum from Rosa26-CAG-LSL-Cas9-P2A-EGFP mouse that was electroporated at E13.5 with a plasmid carrying sgRNA and Cre. Section is
counterstained with DAPI (blue). Scale bar, 100mm. The experimental scheme is shown in the top panel. (b) Immunostaining of GFP and Pax6, Top2b,
Chd7 and Zfpm2 on P7 cerebella from Rosa26-CAG-LSL-Cas9-P2A-EGFP mouse that was electroporated at E13.5 with a plasmid construct expressing Cre
and sgRNA against Top2b (sgTop2b) and a control sequence (sgControl). Quantification of positive cells among GFPþ cells is shown in the right panel. Two
and three pups were analysed for sgControl and sgTop2b, respectively. P¼ 8.567E-06 (for Top2b), P¼0.0037 (for Chd7), P¼0.00046 (for Zfpm2).
Scale bars, 20mm. (c) Immunostaining of GFP (green) and Calbindin (red) of P7 sgControl- and sgTop2b-electroporated cerebella. Arrowheads highlight
mislocalized Purkinje cells. Scale bars, 100 mm. (d) Immunostaining of GFP (green), Ki67 (red) and p27 (white) of the EGL from P7 sgControl- and
sgTop2b-electroporated animals. Quantification of p27þ cells among GFPþ cells was shown in the right panel. Scale bars, 20mm.
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ACTGATCCAATGTATGTATC) or control region (target sequence: GCGACCA
ATACGCGAACGTC) was cloned into the pU6-sgRNA-Cbh-Cre plasmid,
which was modified from pX330 (Addgene #42230) by replacing the hSpCas9 with
Cre coding sequence.
In utero electroporation. In utero electroporation was performed as described
previously54 with some modifications. To ablate Top2b, pU6-sgRNA-Cbh-Cre
(2mg ml 1) was injected into the fourth ventricle and electroporated (35 V, 50
ms-on, 950 ms-off, 5 pulses) into the cerebellar primordial of E13.5 Rosa26-CAG-
LSL-Cas9-P2A-EGFP embryos. Only GFP-labelled cerebella were used for further
analyses. No specific randomization or blinding was performed.
Primary cerebellar granule cell preparation. GNPs were purified from
P7 C57BL/6N pups using percoll gradient centrifugation and plated on matrigel-
coated plates as described previously24. We did not discriminate the gender of
pups. For BrdU analysis, freshly isolated cells were analysed by using the flow
cytometry after staining with an anti-BrdU antibody (BD Pharmingen). In some
experiments, the cells were cultured for defined days with or without either Shh
protein or SAG (200 nM) and collected for analysis. To inhibit Top2b activity, cells
were treated with ICRF-193 (Sigma-Aldrich) in DMSO at 10 mM for 12 h before
collecting them. To delete Chd7 in vitro, Chd7 f/f GNPs were cultured without Shh,
but treated with TAT-Cre (Merck Millipore) at 0.5 mM for 48 h before collecting
them for RNA analysis.
Culture and transfection of HEK293T cells. Mycoplasma-free HEK293T
cells from American Type Culture Collection were cultured in DMEM-Glutamax,
(ThermoFisher Scientific) supplemented with 10% fetal bovine serum
(ThermoFisher Scientific), 100 U ml 1 of penicillin-streptomycin (ThermoFisher
Scientific). For transient transfection, cells were transfected with a DNA-PEI
(Sigma-Aldrich) mixture and collected 48 h later. To establish CHD7 knockout
cell line with the CRISPR-Cas9 technology, HEK293T cells were transfected
with pLentiCRISPR-sgCHD7 plasmid, selected with puromycin (1 mg ml 1) for
7 days before single cell clones were picked up and analysed.
Preparation of cerebellar lysates. Cerebella from adult (2-month-old) mice were
freshly dissected. After snap freezing in liquid nitrogen, tissue was thawed on ice.
Cerebella were homogenized in buffer A (10 mM HEPES, pH 7.9, 10 mM KCl,
1.5 mM MgCl2), and incubated on ice for 30 min. After centrifugation, nuclei were
dissolved in IP buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% Triton X-100, complete protease inhibitor cocktail (Roche)).
Immunoprecipitation and mass-spectrometry. We performed IP as described
previously55. Briefly, nuclei from transfected HEK293T were lysed in IP buffer, and
treated with Benzonase (Sigma-Aldrich, 700 U ml 1) for 1 h at 4 C. Nuclear
extracts were incubated at 4 C overnight with M2 agarose (Sigma-Aldrich) or
protein A/G sepharose (GE healthcare) with primary antibodies. After successive
washing with IP buffer containing 200 mM NaCl, precipitated proteins were
eluted in Laemmli buffer and analysed on western blots. Assays were repeated
at least three times and the representative images were selected. For MS analysis,
precipitated proteins were eluted with 400 ng ml 1 3 Flag peptides
(Sigma-Aldrich) in IP buffer containing 300 mM NaCl. Proteins were digested
in solution with trypsin, and tryptic peptides were analysed with the Orbitrap
XL mass spectrometer. The peptides were identified with the MASCOT searching
engine against the SwissProt database. Uncropped immunoblots are shown in
Supplementary Fig. 10.
Immunostaining. IHC was performed essentially described previously24. The
animals were killed at defined stages and fixed with 4% paraformaldehyde in
PBS (PFA/PBS) overnight, followed by sectioning with cryostat (Leica) and
microtome (Leica). For immunofluorescence on cultured GNPs, cells were fixed
with 4% PFA/PBS for 10 min at room temperature, permeabilized for 5 min in
PBS containing 0.2% Triton X-100. For BrdU staining, sections were treated with
2 N HCl for 30 min at 37 C. Tissue sections and cultured cells were subsequently
subjected to the primary antibody incubation for overnight at 4 C after blocking
with 10% normal donkey serum. For IHC, paraffin sections were incubated
with biotinylated secondary antibodies (Vector) and signals were amplified by
a horseradish peroxidase system (ABC kit, Vector) followed by DAB staining
(Sigma-Aldrich). Fluorescent images were captured using a confocal laser-scanning
microscopy (LSM780 and 800, Zeiss; and SP5, Leica). At least eight sections from
one mouse were stained. Cell counting was done in a double-blind manner
whenever applicable. Representative images were selected from sections from at
least three independent mice.
Antibodies. Antibodies used in this study were the following: BrdU (1:500,
AbDserotec, OBT0030CX), Brg1 (1:200, Santa Cruz Biotechnology, sc-374197),
Cadps2 (1:500, Merck Millipore, ABN326), Calbindin (1:500, Swant, CB38), Chd7
(1:400, Cell Signaling, #6505), cleaved Caspase3 (1:200, Cell Signaling, #9661),
Dab1 (1:200, Sigma-Aldrich, Ab232), Gap43 (1:500, Sigma-Aldrich, G9264),
Ki67 (1:1,000, Abcam, ab15580), Ku70 (1:500, ThermoFisher Scientific,
MA5-13110), GFP (1:500, Life technologies A11122; Abcam ab13970), H3K27Ac
(2 mg per ChIP, Diagenode, pAb-174-050), NeuN (1:500, Merck Millipore,
MAB377), p27 (1:500, BD bioscience, 610241), Parp (1:500, Cell Signaling,),
Pax2 (1:1,000, Life technologies, 71-6000), Pax6 (1:500, Covance, PRB-278P),
Reln (1:200, Merck Millipore, MAB5366), RPA116 (ref. 54), Sox2 (1:200, Santa
Cruz Biotechnology, sc17320), Top2a (1:500, Santa Cruz Biotechnology, sc3659),
Top2b (1:500, Santa Cruz Biotechnology, sc13059) and Zfpm2 (1:200, Santa Cruz
Biotechnology, sc10755). These antibodies were quality-checked in previous
publications.
Quantitative RT–PCR (qRT–PCR). Total RNAs were extracted from cultured
GNPs and tumour tissues with TRI-Reagent (Sigma-Aldrich) and purified with
the RNeasy Mini kit (Qiagen). RNA was transcribed into cDNA using random
primers (dN6, Roche) and M-MLV reverse transcriptase (Promega). cDNA were
quantified by using SYBR gene expression assays (Qiagen) or Taqman Probe with
Absolute Blue qPCR Rox mix (ThermoFisher Scientific), on the CFX96 Real-time
System (Bio-rad). Primers and Probes used for qRT–PCR were listed in
Supplementary Table 2.
Chromatin immunoprecipitation. We performed the IP as described previously54.
Freshly isolated P7 GNPs were fixed with 1% formaldehyde for 10 min at room
temperature, and quenched with 125 mM glycine. Chromatin was extracted and
sonicated for 20 min (30 s on, 30 s off) using a sonicator (Diagenode). After
pre-clearing for 1 h by incubating with protein A/G beads, chromatin lysate
was incubated overnight at 4 C with antibodies. Beads were extensively washed.
DNA–protein complex was eluted, reverse cross-linking and purified using Qiagen
PCR purification column.
Topoisomerase covalent complex assay. Samples were processed according
to the in vivo complex of enzyme (ICE) assay CGNs (ref. 56). CGNs were
treated with etoposide (100 mM) for 1 h at 37 C, and lysed in 1% sarkosyl in
TE (10 mM Tris HCl, pH 7.5; 1 mM EDTA). DNA was sheared by passing the
lysate ten times through a 2 ml syringe with a 25G/8 Gauge needle. Samples were
centrifuged at 57,000 r.p.m. for 20 h at 25 C using 3.3 ml 13 33 mm polyallomer
Optiseal tubes (Beckman Coulter) in a TLN100 rotor (Beckman Coulter).
Precipitated DNA (5 mg) was transferred onto Hybond ECL membranes
(GE Healthcare) using a Bio-Dot SF Microfiltration Apparatus (Bio-Rad).
Membranes were blocked 1 h with Odyssey Blocking Buffer (LI-COR Biosciences),
incubated with anti-TOP2b antibody (1:1,000 dilution), in Odyssey Blocking
Buffer-0.1% Tween20, washed (three times with TBS-0.1% Tween20), incubated
with 1/15,000 IRDye 800CW Goat anti-Rabbit IgG (LI-COR) and finally washed
(three times with TBS-0.1%Tween20 and once with TBS). Dried blots were
analysed and quantified in Odyssey CLx using ImageStudio Odyssey CLx Software.
Gene expression analysis. Total RNA was extracted and subsequently profiled
using the Affymetrix microarray chip (430V2). For RNA-sequencing, a sequencing
library was prepared by using the Illumila TrueSeq Total RNA Sample Prep Kit and
sequenced on the Illumina Hi-Seq 2000, single-end 50 bp reads. For each sample,
about 20,000,000 single-end reads were obtained. RSEM-1.2.15 with Bowtie-1.0.0 is
used to map the reads to the Ensemble mouse reference genome assembly
mm10 transcriptome, and to estimate the expression levels for all the genes.
For both Bowtie and RSEM, default parameters were used. Transcripts per
million reads were adopted to quantify gene expression levels. RNA samples
were sequenced in two batches, with the following samples as the first batch,
Chd7 WT-1, 2, 3; Chd7 heterozygous mutant-1, 2, 3 and Chd7 homozygous
mutant-1, 2, and the rest samples as the second batch. For this, we used ComBat
with default parameters to remove the batch effect57.
ATAC-seq analysis. ATAC-seq was performed with minor modification accord-
ing to the original method33. Briefly, 100,000 GNPs from P7 pups were isolated,
permeabilized and incubated with Tn5 transposase (Illumina) for 30 min at 37 C.
DNA from Tn5-treated cells was purified and used as a template to amplify a DNA
library by PCR. The Libraries were deep-sequenced with HiSeq 2000 v4 paired-end
125 bp. The ATAC-seq analysis was performed according to published papers33,58.
There are three technical replicates for both Chd7 WT and homozygous mutant
GNPs, and two replicates for Chd7 heterozygous mutant GNPs. For each sample,
approximately 30,000,000 paired-end reads were sequenced. Reads were first
trimmed with trim-galore_0.4.1 to remove the adapters and trimmed reads are
mapped with bowtie 1.0.0[1] to mm10 with parameters -X 2000 -m 1. Duplicated
reads and reads from mitochondrial DNA were removed with picard_1.139. To call
the peaks, macs2 2.1.0.20150731 (ref. 59) were applied with parameters -nomodel -
shift -100 -extsize 200. In order to calculate total amount of peaks, peaks given by
macs2 from each of above-mentioned three genotypes were merged when peak
distance is less than 300 b.p. Differential peaks were identified with edgeR (ref. 60)
according to the number of reads mapped to each peak counted by Rsubread
(refs 61,62) for each replicate. Both edgeR and Rsubread were run with default
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parameters. ATAC-seq peaks are annotated using PAVIS (ref. 61) with default
parameters. Coverage density plots were done with deeptools.
Analysis of ChIP-seq. About 5 million GNPs collected from P7 pups were
used for H3K27ac ChIP-seq according to standard ChIP protocol described above.
DNA libraries generated from ChIP-DNA and input-DNA were deep-sequenced
using HiSeq pair-end 125 bp. After trimming with trim_galore, more than
40 million pair-end reads were mapped to mm10 genome with bowtie 1.0.0 with
parameter -X 1000 -m 1. Peaks were called with macs2 with default parameters for
Chd7 and H3K27ac ChIP-seq on GNPs. For Top2b ChIP-seq (WT and Chd7
mutant CGNs), we use homer58 findPeaks with parameter -F 2.0 -P 0.001
-L 2.0 -LP 0.001 -fdr 0.01 -style factor. For the differential peaks of Top2b Chip seq,
MAnorm59 was used with cutoff Po0.01 and fold change42. SE was called using
homer findPeaks with parameter -style super. ChIP-seq peaks are annotated
using PAVIS (ref. 61) with default parameters. Coverage density plots were done
with deeptools.
GO analysis and GSEA. Gene ontology biological process was performed
with David6.7 (http://david.ncifcrf.gov). GO term with the Benjamini adjusted
P valueo0.05 is considered to be significantly enriched. For custom gene sets,
GSEA (www.broadinstitute.org/gsea) was performed using default parameter.
FDRo25%, Po0.05 was considered to be significantly associated.
Statistical methods. Two-tailed Student’s t-test with equal variance was
performed to compare two groups. The KruskalWallis test was performed
for tests with three groups. Pearson test and Chi-squared test were performed
as mentioned. For significance test, *means Po0.05. Error bar stands for
mean±s.d.
Data availability. All sequencing and microarray data have been submitted to the
US National Institute of Health GEO database (https://www.ncbi.nlm.nih.gov/gds)
under the accession number GSE93741.
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